| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |